1. Pfizer og Biontech på sporet mod produktionsmål for 2020 (04/12)
2. Direktørskift i Contera Pharma ændrer ikke planer for børsnotering i Sydkorea (04/12)
3. Y-mabs indgår partnerskab med Takeda (04/12)
4. Her er de vigtigste nyheder fra MedWatch i uge 49 (04/12)
5. Lundbeck udpeges som favoritaktie af schweizisk storbank (04/12)
6. Novo Nordisk sender fedmebehandling til godkendelse i USA (04/12)
7. AGC Biologics investerer milliardbeløb i ny fabrik i Danmark (04/12)
8. Lundbeck-veteran bliver topchef i biotekselskab med børsdrøm (04/12)
9. Biotekselskab samarbejder med det amerikanske forsvar om næsespray mod coronavirus (04/12)
10. Novo-selskab øger eksponering mod kapitalfonde (04/12)
11. Brexit: Vi er i de afgørende dage nu (04/12)
12. Moderna lover mindst 100 millioner doser i begyndelsen af 2021 (04/12)

• Vice President Global Quality Assurance and Regulatory Affairs – Etac Group
• Global Sales Manager – MC2 Therapeutics
• Senior Sustainability Manager - ALK
• Director of Clinical Quality Assurance Operations – Orphazyme
• Clinical Trial Manager, Clinical Operations - Symphogen
• Trial Project Manager to lead global clinical trials in a time of great change - Novo Nordisk
• Associate CMC Project Manager - Genmab
• Quality Assurance Specialist - Orifarm
• QA Manager - Ascendis Pharma
• Manufacturing Scientist - FUJIFILM Diosynth Biotechnologies
• Infrastructure Director - Genmab
• Senior Manager Business Development - Ascelia Pharma
• Senior Medical Writer - Orphazyme
• International Portfolio Manager - Orifarm
• BRIDGE – Translational Excellence Programme: Call for Outstanding Postdocs and Experienced Mentors interested in Translational Medicine
• Senior contract Manager - Genmab
• CMC Regulatory Affairs Manager - Bavarian Nordic
• Senior Manager, QA GMP - Genmab
• Experienced Scientist - LEO Pharma
• Manager of Medical Writing - Orphazyme
• Regulatory Affairs Specialist - Contura
• Trial Start-up Manager specialised in start-up activities to prepare and improve our clinical trials - Novo Nordisk
• Udstyrskemiker til Aseptic Production, Equipment Team – 2 årlig stilling - ALK
• CMC Specialist at VarmX BV
• QA Projektleder for implementering af SAP S/4 HANA - Nomeco
• Kvalitetschef, QP/RP til Specific Pharma A/S
• Senior Scientist in Molecular Pharmacology - Zealand Pharma
• Medical Doctor - ALK
• Global Pharmaceutical Expert – Europe, Business Development & Licensing - KHIDI
• Director Pharmacology & New Target Discovery - Y-mAbs
• Erfaren udstyrskemiker til Aseptic Production, Equipment Team - ALK
• Brand and Marketing Manager, biomee™ – MC2 Therapeutics
• Head of PR/Communication – MC2 Therapeutics A/S
• Global Pharmaceutical Expert – Europe, Regulatory Affairs - KHIDI
• Principal Scientist - Symphogen
• Director CMC - Orphazyme
• Pioneering Drug Delivery Expert - LEO Pharma
• Senior Project Manager, Unilabs

Se flere

1. Janssen turns to Danish startup for pill to replace the need to inject drugs (03/12)
2. Experiences from Covid-19 will create success for Demant's virtual product launch (02/12)
3. Danish Business Authority's decision causes Lundbeck to downgrade guidance (02/12)
4. Novo Nordisk loses court case against Sanofi over Danish press statement (02/12)
5. Incyte expands in Scandinavia and plans to more than double its employees (02/12)

1. Amerikansk børsbaby brager i vejret - runder 100 mia. dollar i værdi (04/12)
2. Bilejere er sluppet billigt med afgiftsstigning (04/12)
3. ONE sætter endeligt tal på tab i Stillehavet (04/12)
4. Branche tilfreds med grøn bilaftale (04/12)
5. Afslutningen på finanskrisens bankkrak bliver formentlig uden Henrik Bjerre som nøgleperson (04/12)
6. David Trads: Journalistikken er taberen i splittet amerikansk mediebillede (04/12)
7. LD Fonde kan fortsætte trods frigivelse af hele feriepengeformuen (04/12)
8. Regeringen vil have 775.000 grønne biler på de danske veje i 2030 (04/12)
9. Forenet Kredit gør valgmøder virtuelle (04/12)
10. Aarhusiansk boligudvikler tager hul på forsinket byhaveprojekt (04/12)